Citizens Maintains Market Outperform on Stryker, Lowers Price Target to $400

Benzinga Newsdesk www.benzinga.com Negative 91.8%

Neg 91.8% Neu 0% Pos 0%

Citizens analyst David Turkaly maintains Stryker (NYSE:SYK) with a Market Outperform and lowers the price target from $440 to $400.